Research and development - Press Releases

Date	Title	Company
10-Jan-2023	No More Needles: TRUMPF and RSP Systems Want to Make Blood Glucose Monitoring Easier for People with Diabetes	TRUMPF Photonic Components
10-Jan-2023	Inflexion provides Partnership Capital minority funding to Proteros	Inflexion
10-Jan-2023	ProtonDx and Katalyst Announce Strategic Partnership to Distribute Dragonfly™ In Vitro Diagnostic	ProtonDx
10-Jan-2023	Novo Holdings invests in proteomics technology company, Evosep	Novo Holdings
09-Jan-2023	Cartherics granted first patent in China for multiple development candidates	Cartherics
06-Jan-2023	New AI editing tool to speed up editing manuscripts	Cactus Communications
05-Jan-2023	STEMart Introduces API Impurity Identification Services for Medical Devices	STEMart
05-Jan-2023	CD BioSciences Introduces Label-Free Live Cell Imaging Services for Bio-Research	CD BioSciences
05-Jan-2023	CD BioSciences Introduces Various Solutions for Autophagic Cell Death Studies	CD BioSciences
04-Jan-2023	CD Bioparticles Announces Magnetofection Reagents for Gene Expression	CD Bioparticles
04-Jan-2023	CD Bioparticles Introduces Hydrophobic Interaction Chromatography Resins for Purification of Macromolecules	CD Bioparticles
04-Jan-2023	Creative Diagnostics Expands Its Monoclonal Antibodies Offering to Customers	Creative Diagnostics
04-Jan-2023	Creative Diagnostics Introduces New Hemagglutination Inhibition Assay Services	Creative Diagnostics
03-Jan-2023	Senior appointments at Copley signal the start of a new phase of growth	Copley
23-Dec-2022	Alfa Chemistry Enriches API Supply by Adding Lenalidomide, Parecoxib Sodium, and Rivaroxaban	Alfa Chemistry
23-Dec-2022	CD Formulation Launches One-stop OEM/ODM and Analytical Testing Solutions for Cosmetics	CD Formulation
23-Dec-2022	Nearly 480 Cosmetic Ingredients Are Now Available at CD Formulation	CD Formulation
22-Dec-2022	Kancera submits regulatory application to conduct clinical study in ovarian cancer and enters into collaboration with the Nordic Society of Gynaecological Oncology	Kancera
20-Dec-2022	2cureX reaches 2022 geographic rollout goal of 20 countries	2cureX
16-Dec-2022	Alchemab Therapeutics and Medicines Discovery Catapult Awarded £1.7 Million Grant From Innovate UK to Accelerate Development of Disease-Modifying Therapy for Huntington’s Disease	Medicines Discovery Catapult